Meta-analysis for cyclin E in lung cancer survival

被引:33
作者
Huang, Li-nian [1 ]
Wang, Dong-sheng [1 ,2 ]
Chen, Yu-qing [1 ]
Li, Wei [1 ]
Hu, Feng-dan [3 ]
Gong, Bei-lei [1 ]
Zhao, Cheng-Ling [1 ]
Jia, Wei [1 ]
机构
[1] Bengbu Med Coll, Dept Respirat, Affiliated Hosp 1, Anhui Prov Key Lab Clin Basic Res Resp Dis, Bengbu 233004, Anhui, Peoples R China
[2] Anhui Prov Hosp, Dept Respirat, Hefei, Peoples R China
[3] Wuhe Cty Hosp, Dept Respirat, Wuhe, Anhui, Peoples R China
关键词
Lung cancer; Cyclin E; Prognosis; Meta-analysis; POTENTIAL PROGNOSTIC MARKER; OF-THE-LITERATURE; CELL-CYCLE; BREAST-CANCER; E EXPRESSION; CARCINOMAS; PROLIFERATION; OVEREXPRESSION; REGULATORS; TRIALS;
D O I
10.1016/j.cca.2011.12.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: To assess the prognosis value of cyclin E expression in survival of patients with lung cancer (LC), we performed a systematic review of the literature with meta-analysis. Methods: Electronic databases were used to identify published studies before August 2011. Pooled hazard ratio (HR) with 95% confidence interval (95% CI) was used to estimate the strength of the association of cyclin E expression with survival of LC patients. Heterogeneity and publication bias were also assessed. Results: Fourteen studies (2606 cases) were eligible and subjected to analysis. Cyclin E over-expression was found to be a strong predictor of poor prognosis in LC patients (HR: 1.38, 95% CI: 1.07-1.79; P = 0.014). When only non-small cell lung cancer (NSCLC) was considered, the combined HR was 1.53 (95% Cl: 1.19-1.97, P = 0.001). A significant association was also evident when the analysis was limited to studies involving adenocarcinoma (AD), but not squamous cell carcinoma (SQ). Publication bias was absent. Sensitivity analyses suggested that the summary statistics obtained should approximate the actual average. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:663 / 668
页数:6
相关论文
共 37 条
[1]   The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung [J].
Anton, RC ;
Coffey, DM ;
Gondo, MM ;
Stephenson, MA ;
Brown, RW ;
Cagle, PT .
MODERN PATHOLOGY, 2000, 13 (11) :1167-1172
[2]   Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis [J].
Banerjee, Indranil .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2010, 25 (07) :449-458
[3]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[4]   Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions [J].
Bito, T ;
Ueda, M ;
Ito, A ;
Ichihashi, M .
JOURNAL OF CUTANEOUS PATHOLOGY, 1997, 24 (05) :305-308
[5]   Preventing the lung cancer epidemic [J].
Boyle, P ;
Dresler, C .
ANNALS OF ONCOLOGY, 2005, 16 (10) :1565-1566
[6]   A biological staging model for operable non-small cell lung cancer [J].
Cox, G ;
Jones, JL ;
Andi, A ;
Waller, DA ;
O'Byrne, KJ .
THORAX, 2001, 56 (07) :561-566
[7]   Loss of cell cycle regulators p27Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival [J].
Del Pizzo, JJ ;
Borkowski, A ;
Jacobs, SC ;
Kyprianou, N .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1129-1136
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Active cyclin A CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas [J].
Dobashi, Y ;
Shoji, M ;
Jiang, SX ;
Kobayashi, M ;
Kawakubo, Y ;
Kameya, T .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :963-972
[10]   Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas [J].
Dobashi, Y ;
Jiang, SX ;
Shoji, M ;
Morinaga, S ;
Kameya, T .
JOURNAL OF PATHOLOGY, 2003, 199 (02) :208-220